The Evaluation of Single and Combined Guidelines-Recommended Tumor Markers in the Diagnosis and Classification of Primary Lung Cancer

WANG Tieshan, WANG Zhenzi

PDF(1283 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1283 KB)
Labeled Immunoassays and Clinical Medicine ›› 2023, Vol. 30 ›› Issue (4) : 550-554. DOI: 10.11748/bjmy.issn.1006-1703.2023.04.003
Clinical Investigation

The Evaluation of Single and Combined Guidelines-Recommended Tumor Markers in the Diagnosis and Classification of Primary Lung Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 30(4): 550-554 https://doi.org/10.11748/bjmy.issn.1006-1703.2023.04.003

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1283 KB)

Accesses

Citation

Detail

Sections
Recommended

/